1st Quarter - Report

MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) for INOVIO PHARMACEUTICALS

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
$30,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report (this page) Apr 24, 2018 $30,000 Replaced
1st Quarter - Amendment May 23, 2018 $30,000 Yes

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Government Relations Services including developing strategies to achieve legislative goals, inclusion of MERS on list of neglected diseases at FDA

LobbyistCovered position, as disclosed
MONA G MOHIB New Director, Office of Intergovernmental Affairs, Dept. of Labor; Special Assistant, Office Intergovernmental Affairs, White House; Assoc. Director, Office Intergovernmental Affairs, White House
ROBERT WASINGER —

Contacted: SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.